Drug intelligence / Profile preview

fluocinolone acetonide + urea

Development stage
Approved
Lead developer
Taro
Modality
Small Molecules
Administration
Topical
01

Overview

Fluocinolone acetonide + urea is a topical combination product containing a synthetic corticosteroid (fluocinolone acetonide) and a keratolytic/humectant agent (urea), used primarily for the treatment of corticosteroid-responsive dermatoses, such as eczema, dermatitis, psoriasis, and other inflammatory skin disorders. Fluocinolone acetonide acts as an anti-inflammatory agent by binding to the glucocorticoid receptor, altering gene transcription, reducing the production of pro-inflammatory mediators (such as prostaglandins and leukotrienes) via phospholipase A2 inhibition, and inducing annexin proteins. Urea improves skin hydration by breaking down keratin, which helps enhance drug penetration and reduces scaling. The combination targets both inflammation and hyperkeratosis commonly seen in chronic dermatoses[1][3][8].

Brand names
NOXIPAK
Other names
fluocinolone acetonide and urea kitfluocinolone 0.01 %-urea 20 %-silicone tape topical kit
02

Targets

GR (Glucocorticoid receptor)PLA2 (Phospholipase A2 group IID)ANXA1 (Annexin A1)

Beyond the preview

Go deeper on fluocinolone acetonide + urea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluocinolone acetonide + urea.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call